Pgap3-KO 基因敲除小鼠

下单100%中奖,最高可得千元京东卡
复苏/繁育服务
产品名称

Pgap3-KO 基因敲除小鼠

产品编号

S-KO-09323

品系全称

C57BL/6JCya-Pgap3em1/Cya

品系背景

C57BL/6JCya

品系编号

KOCMP-320655-Pgap3-B6J-VA

品系状态

使用本品系发表的文献需注明: Pgap3-KO 基因敲除小鼠 mice (Strain S-KO-09323) were purchased from Cyagen.
交付类型
周龄
性别
基因型
数量

基本信息

基因研究概述

质控标准

基因
基因全称
post-GPI attachment to proteins 3
基因别称
CAB2,D430035D22Rik,Perld1
染色体号
Chr 11 (Mouse)
转录本 ID
NCBI: NM_001033537.2 | Ensembl: ENSMUST00000090827
修饰方式
全身性基因敲除
靶向范围
Exon 2~4
敲除长度
~7288 bp
品系说明
该品系是基于策略设计时的数据库信息制作而成,建议您在购买前查询最新的数据库和相关文献,以获取最准确的表型信息。
表型提示
MGI:2444461Mice homozygous for a targeted allele exhibit abnormal head and tail morphology, growth retardation, limb glasping, altered T cell proliferation response and increased susceptibility to EAE.
PGAP3,也称为PGAP3基因,编码的是PGAP3蛋白。PGAP3蛋白参与多种生物学过程,包括细胞增殖、分化、凋亡、代谢和信号转导。PGAP3蛋白与多种蛋白质相互作用,形成复合物,共同调控这些生物学过程。PGAP3蛋白在多种组织中表达,包括脑、心脏、肝脏、肾脏和骨骼肌。PGAP3基因突变与多种疾病相关,包括Hyperphosphatasia with Mental Retardation Syndrome 4 (HPMRS4)、Skeletal Dysplasia、Sinonasal Undifferentiated Carcinoma (SNUC)、Gastric Cancer、Mabry Syndrome、Pancreatic Cancer、Brachytelephalangy、Pancreatic Adenocarcinoma (PDAC)、Cervical Cancer和Breast Cancer。这些疾病的发生发展与PGAP3蛋白的功能异常密切相关。

PGAP3基因突变与Hyperphosphatasia with Mental Retardation Syndrome 4 (HPMRS4)密切相关。HPMRS4是一种罕见的常染色体隐性遗传疾病,表现为发育迟缓、智力障碍、面部畸形和血清碱性磷酸酶升高。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响GPI锚定蛋白的合成和功能,进而导致HPMRS4的发生[1][5][8]。此外,PGAP3基因突变还与Skeletal Dysplasia相关。Skeletal Dysplasia是一种骨骼发育异常的疾病,表现为骨骼短小、畸形和生长迟缓。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响骨骼发育和生长[2]。PGAP3基因突变还与Sinonasal Undifferentiated Carcinoma (SNUC)相关。SNUC是一种罕见的颅底肿瘤,具有侵袭性和预后差。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响肿瘤的发生和发展[3]。

PGAP3基因突变还与Gastric Cancer相关。Gastric Cancer是一种常见的恶性肿瘤,具有较高的发病率和死亡率。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响肿瘤的发生和发展[4]。PGAP3基因突变还与Mabry Syndrome相关。Mabry Syndrome是一种罕见的常染色体隐性遗传疾病,表现为发育迟缓、智力障碍、面部畸形和骨骼发育异常。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响Mabry Syndrome的发生[5]。PGAP3基因突变还与Pancreatic Cancer相关。Pancreatic Cancer是一种常见的恶性肿瘤,具有较高的发病率和死亡率。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响肿瘤的发生和发展[6]。PGAP3基因突变还与Brachytelephalangy相关。Brachytelephalangy是一种罕见的常染色体隐性遗传疾病,表现为手指和脚趾短小。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响Brachytelephalangy的发生[7]。PGAP3基因突变还与Cervical Cancer相关。Cervical Cancer是一种常见的恶性肿瘤,具有较高的发病率和死亡率。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响肿瘤的发生和发展[9]。PGAP3基因突变还与Breast Cancer相关。Breast Cancer是一种常见的恶性肿瘤,具有较高的发病率和死亡率。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响肿瘤的发生和发展[10]。

PGAP3基因突变与多种疾病相关,包括Hyperphosphatasia with Mental Retardation Syndrome 4 (HPMRS4)、Skeletal Dysplasia、Sinonasal Undifferentiated Carcinoma (SNUC)、Gastric Cancer、Mabry Syndrome、Pancreatic Cancer、Brachytelephalangy、Pancreatic Adenocarcinoma (PDAC)、Cervical Cancer和Breast Cancer。这些疾病的发生发展与PGAP3蛋白的功能异常密切相关。PGAP3基因突变导致PGAP3蛋白功能异常,从而影响细胞增殖、分化、凋亡、代谢和信号转导等生物学过程,进而导致疾病的发生和发展。PGAP3基因突变的研究有助于深入理解这些疾病的发病机制,为疾病的治疗和预防提供新的思路和策略。

参考文献:
1. Alhaidari, Abdulmajeed I, Albakri, Amani S, Alhumaidi, Suzan S. 2022. A Novel PGAP3 Gene Mutation-Related Megalocornea Can Be Misdiagnosed as Primary Congenital Glaucoma. In Cureus, 14, e29387. doi:10.7759/cureus.29387. https://pubmed.ncbi.nlm.nih.gov/36304370/
2. Maddirevula, Sateesh, Alsahli, Saud, Alhabeeb, Lamees, Shaheen, Ranad, Alkuraya, Fowzan S. 2018. Expanding the phenome and variome of skeletal dysplasia. In Genetics in medicine : official journal of the American College of Medical Genetics, 20, 1609-1616. doi:10.1038/gim.2018.50. https://pubmed.ncbi.nlm.nih.gov/29620724/
3. Heft Neal, Molly E, Birkeland, Andrew C, Bhangale, Apurva D, McKean, Erin L, Brenner, J Chad. 2021. Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene. In BMC cancer, 21, 636. doi:10.1186/s12885-021-08370-x. https://pubmed.ncbi.nlm.nih.gov/34051734/
4. Wang, Dong, Hao, Siyu, He, Hongjie, Fu, Songbin, Yu, Jingcui. 2023. Contribution of PGAP3 co-amplified and co-overexpressed with ERBB2 at 17q12 involved poor prognosis in gastric cancer. In Journal of cellular and molecular medicine, 27, 2424-2436. doi:10.1111/jcmm.17828. https://pubmed.ncbi.nlm.nih.gov/37386793/
5. Thompson, Miles D, Li, Xueying, Spencer-Manzon, Michele, Kinoshita, Taroh, Carpenter, Thomas O. 2023. Excluding Digenic Inheritance of PGAP2 and PGAP3 Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with PGAP2 Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3). In Genes, 14, . doi:10.3390/genes14020359. https://pubmed.ncbi.nlm.nih.gov/36833286/
6. Tan, Marcus C B, Isom, Chelsea A, Liu, Yangzi, Zhou, Dan, Gamazon, Eric R. 2024. Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism. In EBioMedicine, 106, 105233. doi:10.1016/j.ebiom.2024.105233. https://pubmed.ncbi.nlm.nih.gov/39002386/
7. Sakaguchi, Tomohiro, Žigman, Tamara, Petković Ramadža, Danijela, Matsumoto, Naomichi, Barić, Ivo. 2018. A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum. In Human genome variation, 5, 18005. doi:10.1038/hgv.2018.5. https://pubmed.ncbi.nlm.nih.gov/29531774/
8. Abdel-Hamid, M S, Issa, M Y, Otaify, G A, Elbendary, H M, Zaki, M S. 2017. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation. In Clinical genetics, 93, 84-91. doi:10.1111/cge.13033. https://pubmed.ncbi.nlm.nih.gov/28390064/
9. Hao, Na, Li, Mingyang, Wang, Jiachen, Jia, Qingge, Sui, Fang. 2023. High PGAP3 expression is associated with lymph node metastasis and low CD8+T cell in patients with HER2+ breast cancer. In Pathology, research and practice, 251, 154890. doi:10.1016/j.prp.2023.154890. https://pubmed.ncbi.nlm.nih.gov/37839361/
10. Jun, Tian, Chen, Wang, Hailing, Cheng, Ning, Wang, Qinxue, Cao. 2021. The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis. In Human cell, 34, 878-888. doi:10.1007/s13577-021-00493-4. https://pubmed.ncbi.nlm.nih.gov/33591461/